Authors


Mohamed Jalloh, PharmD

Latest:

Hypertension: Revealing the Silent Killer

Hypertension is a leading modifiable risk factor for heart disease and stroke.



Karen von Koeckritz, PharmD

Latest:

Generic Drug Trends-What's Next?

Big changes are coming in the generic marketplace worldwide in the coming decade.


Rita El-Khoury, PharmD Candidate

Latest:

Case Studies (January 2020)

What could be causing this patient's involuntary, repetitive movements in her arms and legs?



Vincent Ducoulombier, MD

Latest:

Contribution of Phone Follow-up to Improved Adherence to Oral Osteoporosis Treatment

The authors studied the usefulness of a regular telephone follow-up to improve adherence to oral antiosteoporosis treatments. Their results support such follow-up and the use of this strategy in routine clinical practice.


Brahim K. Bookhart, MBA, MPH

Latest:

Economic Model Comparing Rivaroxaban and Enoxaparin for Post-Orthopedic VTE Prophylaxis

This analysis evaluates-from a US payer's perspective-the economic impact of using rivaroxaban versus enoxaparin for thromboprophylaxis following total hip or knee replacement surgery.


Chief Medical Officer, Cardinal Health Specialty Solutions

Latest:

Trends That Will Affect Specialty Health Care Into the Future 

Current developments and innovations that will shape the future of specialty pharmacy.


Kimberly Firtz, PharmD, MSPBA Candidate

Latest:

The Benefits of the Hub for Specialty Patients

Pharmaceutical manufacturers depend on hubs to act as connectors between various stakeholders across the specialty drug prescribing process.


Joseph S. Ross, MD, MHS

Latest:

Cancer Therapeutic Clinical Trials Supporting FDA Approval and Compendia Inclusion

Evidentiary standards for new or supplementary cancer therapeutic indication approvals by the FDA are consistent with off-label indication inclusions on Medicare-referenced compendia.


Jocelyn Zazyczny Konrad, RPh

Latest:

The Road to Wellness

A chain pharmacy implements an integrated care program featuring pharmacists and health care coaches who provide in-store counseling.


James P. Tursi, MD

Latest:

Costs of Collagenase Clostridium Histolyticum and Fasciectomy for Dupuytren's Contracture

A retrospective cohort analysis was conducted to compare disease-specific healthcare resource utilization and the costs of collagenase clostridium histolyticum and fasciectomy among adult Dupuytren’s contracture patients.


Sheila Seed, PharmD, MPh, CTH, AFTM, RCPS (GLASG)

Latest:

Point-of-Care Testing Offers New Opportunities

Consider these steps for pharmacists to further evolve their role as the pandemic continues to put pressure on the health care system.


Susan Goodin, PharmD, FCCP, BCOP

Latest:

Safe Handling of Oral Chemo Agents in Community Settings

Dr. Goodin is the director of the division of pharmaceutical sciences at the Cancer Institute of New Jersey and associate professor of medicine, division of medical oncology, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School, New Brunswick.


Frederick L. Newman, PhD

Latest:

Quantitative Analysis of 2 Treatment Options for Osteoarthritis in Adults: Intra-Articular Hyaluronan Products and Diacerein

Empirical findings suggest that hyaluronan injections and diacerein are similarly effective. Yet the authors found that monetary savings could be realized when conservative treatment with diacerein is chosen.


Brittany Myers-O'Shea, PharmD

Latest:

White-Coat Hypertension: A Closer Look

Everything you need to know about WCH from diagnosis, treatment, and a review of the literature.


Lauren B. McKnight, PharmD, CPP

Latest:

Pain Management: Non-Opioid Medications

Given the disadvantages of opioids, including side effects and potential for addiction, non-opioid medications play an important role in pain management.


Eileen Stellefson Myers, MPH, RDN, LDN, CEDRD, FAND

Latest:

Nutrition Counseling for Patients with Prediabetes or Diabetes

More than 86 million Americans over the age of 20 have prediabetes, 29 million Americans are diagnosed with diabetes, and another 8.1 million Americans are living with undiagnosed diabetes.



Timothy D. Aungst, PharmD

Latest:

What is the Current Status of Bioingestible Sensors for Medication Adherence?

Sensors that can be attached to insulin pens, smart auto-injectors for patients with MS, sensors for inhalers, smart pill bottles, and bioingestible sensors are some of the evolving technologies.


Mark P. Walberg, PharmD, PhD

Latest:

Medicare Part D Optimization: Potential Out-of-Pocket Savings Through Plan Reexamination

Medicare Part D plans can change their cost-sharing structure and formularies every year. As such, beneficiaries should annually reevaluate plan offerings to minimize their out-of-pocket costs.


Peter Griffin, PharmD

Latest:

Pharmacist Feature Friday: My Journey into Specialty Pharmacy

Making the patients’ lives easier is at the heart of my job.


Creighton Kaiser, PharmD

Latest:

Infection Specialists and Pharmacists Share Responsibility for Ensuring Patient Safety

Collaboration Is a necessary component of successful compliance with USP , and technology can help.


Sheila Arquette, RPh

Latest:

“NASP in Action” Highlights Organization’s Efforts to Elevate Specialty Pharmacy

A session during the National Association of Specialty Pharmacy (NASP) 2020 Annual Meeting & Expo Virtual Experience, held September 14 to 18, 2020, highlighted some of the nonprofit’s activities.


Michelle Then, PharmD, MBA

Latest:

High-Value Medications: Preserving Value after a Frosty Flounder

The pharmaceutical industry continually develops novel therapeutics, many of which require refrigeration and are associated with high costs. In the event of such temperature excursions as a breach in the cold chain protocol, pharmacists are looked upon as experts who can deter- mine whether medications are still viable.



Nicol D. Brown, PharmD, MSCR

Latest:

Evaluation of Dual Versus Triple Therapy for Hepatitis C

In this retrospective chart review, patients with hepatitis C had a sustained virologic response with either dual or triple therapy.


Keith Bruhnsen, MSW

Latest:

Strategies to Improve PBM Management of an Employee Prescription Drug Plan

Description of strategies that employers can consider to better manage their PBM relationship to optimize their pharmacy benefit costs.


Susy Chen, MD

Latest:

Cost-Effectiveness of Extended-Release Carbidopa-Levodopa for Advanced Parkinson's Disease

Existing levodopa therapies for Parkinson’s disease often provide inadequate symptom control after prolonged treatment. This study assessed the cost-effectiveness of an extended-release carbidopa-levodopa formulation (IPX066).


Kristyn McKnight

Latest:

Managing COVID-19 at Home: A Toolbox

Helpful patient education suggestions for the successful management of COVID-19 at home and when it is appropriate to seek medical attention.